Studies have revealed that Cav1 or lipid rafts are implicated in neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) [18–20], and that Cav1 is also involved in non-neural diseases such as cancer and diabetes [21, 22]. Here, CAV1 is linked to early-onset autosomal dominant Alzheimer disease.